Stabilized, sterilized collagen scaffolds with active adjuncts attached
Bioimplants and methods of making the bioimplants are provided. The bioimplants comprise biological tissues having conjugated thereto adjunct molecules. The biological tissues are sterilized with a chemical sterilizing agent, such as a water soluble carbodiimide. The processes of making the bioimplants include a process in which an adjunct molecule is conjugated to a biological tissue during the sterilization process.
1. A bioimplant comprising a chemically sterilized biological tissue and at least one heparin adjunct, wherein the heparin adjunct is covalently conjugated to the biological tissue and wherein the chemically sterilized biological tissue is sterilized with a carbodiimide, optionally in the presence of an alkanol, selected from the group consisting of C2-C4 alkanol.
2. The bioimplant of claim 1 , wherein the chemically sterilized biological tissue is crosslinked with a carbodiimide, optionally in the presence of a bifunctional crosslinking agent.
3. The bioimplant of claim 1 , wherein the biological tissue comprises processed tissue in native form.
4. The bioimplant of claim 1 , wherein the biological tissue comprises collagen, purified collagen or solubilized collagen.
5. The bioimplant of claim 1 , wherein the heparin adjunct retains at least some of its native activity after it has been conjugated to the biological tissue.
6. The bioimplant of claim 1 , wherein the heparin adjunct is adapted to be released in vivo and the heparin adjunct, once release in vivo possesses at least some of its native activity.
7. The bioimplant of claim 1 , wherein the chemically sterilized biological tissue is pericardium.
8. The bioimplant of claim 1 , wherein the chemically sterilized biological tissue is a sheet of pericardium.
9. The bioimplant of claim 3 , wherein said processed tissue in native form comprises decellularized fascia.